News

Sciad News Sciad News UK biotech booms 65% since 2016 as sector attracts record investment 2nd April 2019 Sciad Newswire / Solentim and Valitacell announce a total of €3.5m funding to produce an integrated platform to deposit, culture, profile and select optimal cells for the manufacture of life-saving biological medicines. Building on the ex”> Client News Valitacell and Solentim secure €3.5m funding to optimise the development of new biologics and cell therapies A consortium, consisting of Valitacell, Solentim and Microcoat, has been awarded €2.5million under the highly competitive H2020 Fast Track to Innovation (FTI) initiative, and a further €1million from other sources 27th March 2019 Client News Life Science Integrates launches new Bio Integrates to address the biggest challenges impacting the pharma and biotech sector 21st March 2019 Client News Client News N-SIDE launches new innovative software for end-to-end clinical supply chain optimization Unique management tool for minimizing costs, drug waste and risk 12th March 2019 Client News Client News Procarta announces €1.5 million investment for new class of antibiotics to combat antimicrobial resistance 5th March 2019 Client News Client News Valitacell and Solentim announce collaboration to accelerate discovery and development of biologic drugs and advanced cell therapies 21st February 2019 Client News Mark Johnson joins The RSA Group as Partner 6th February 2019 Client News Client News £30 Million global cardiovascular disease challenge – now open for applications 24th January 2019 Client News Hypha Discovery launches new PolyCYPs® kits to support drug development and candidate optimisation 22nd January 2019 Client News Client News Solentim and ATUM announce technology collaboration to enable rapid, high expression, stable cell line development 14th January 2019